Advertisment
|
|
|
news roundup
ONO will use Medidata’s Clinical Cloud to evaluate expanded oncology uses for Opdivo in Japan.
Through a partnership in Oslo, Norway, Radiant Sage is expanding its clinical trial and imaging services in the EU.
In November 2015, the EMA reportedly told the BMJ it was investigating the INRatio device and its use in the ROCKET-AF trial.
LabConnect, a provider of global central laboratory services, has built a new biorepository facility to expand services and better meet the evolving needs of the industry.
|
|
Risk-Based Monitoring
The CRO has chosen Bioclinica’s COMPASS technology to implement effective RBM services consistent with global regulatory authority initiatives.
TRI will make MCC’s Risk Assessment and Mitigation Management Tool available as part of its OPRA Risk-Based Monitoring and Quality Management platform.
|
|
|
advertisment
|
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Advertisment
|
|
|
Blog Posts
The immune system is an ideal anti-cancer agent because it controls an array of diverse immune cells that have a high degree of specificity.
|
|
|
articles
Considering the caregiver model in nursing homes, the environment appears optimal to recruit and retain Alzheimer’s patients using patient-centric models.
|
|
|
|
Using Smarter Testing Strategies to Optimize Clinical Protocol Development. Download your copy of the new e-book from ACM Global Central Lab.
 Click here
|
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
